Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gwenaëlle Douaud and colleagues reveal new evidence that shows how development, ageing, and disease processes are related in the brain.

A mother and her daughter, representing two sides of the life spectrum undergoing mirroring changes in the same network of brain regions © Marc Debnam
A mother and her daughter, representing two sides of the life spectrum undergoing mirroring changes in the same network of brain regions

Several theories link processes of development and ageing in humans. In neuroscience, one model suggests that age-related brain degeneration in healthy humans mirrors development: in other words, the areas of the brain that are thought to develop later also degenerate earlier. So far, the MRI studies looking for such a link between healthy ageing and development in the grey matter have led to different, and sometimes contradictory, results.

In a paper published in Proceedings of the National Academy of Sciences on 24 November 2014, Gwenaëlle Douaud, with colleagues from the Oxford Centre for Functional MRI of the Brain and elsewhere, presents data-driven evidence that supports this model of mirroring development and ageing.

The team analysed brain structural variation using MRI scans across 484 healthy participants (between the ages of 8 and 85). They were able to see a particular network of brain regions which develops relatively late during adolescence and shows accelerated degeneration in old age compared with the rest of the brain.

This same network is also particularly vulnerable to unhealthy developmental and ageing processes, such as schizophrenia and Alzheimer’s disease. It is also associated with intellectual ability and episodic memory, whose impairment contributes to key symptoms of schizophrenia and Alzheimer’s disease.

These regions seem to be more vulnerable than the rest of the brain to both schizophrenia and Alzheimer's. - Gwenaëlle Douaud

The results suggests that the common spatial pattern of abnormalities observed in these two disorders, which emerge at opposite ends of the life spectrum, might be influenced by the timing of their pathological processes in disrupting healthy cerebral development and ageing.

This research therefore provides, for the first time, evidence of a fundamental link between development, ageing, and disease processes in the brain.

Similar stories

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

Director of MRC Brain Network Dynamics Unit appointed

From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.